Abstract

Keywords
Anticoagulants,Oral (313)Antiretrovirals (320)Asparaginase (321)Bleomycin (332)Breast cancer treatment (319)Bupivacaine (333)Ceftriaxone (323)Drug-drug interactions (335)Drugs (327)Dupilumab,mepolizumab,omalizumab (322)Enfortumab vedotin (310)Escitalopram (326)Hepatitis B vaccine (307)Ibuprofen (329)Immune checkpoint inhibitors (308,312)Interleukin-17 Inhibitors (315)KRAS (G12C) Inhibitors (334)Medications (309)Multiple myeloma targeted therapy (336)NSAIDs,analgesics,antiplatelets (314)Omadacycline (331)Paclitaxel (325)Program cell death-1 and programmed death-ligand-1 inhibitors (328)Pembrolizumab (317)Rifampicin (330)Rimegepant (316)Semaglutide (318)Tafamidis (337)Teriflunomide (311)Vancomycin (324)
Get full access to this article
View all access options for this article.
